JP2004530414A5 - - Google Patents

Download PDF

Info

Publication number
JP2004530414A5
JP2004530414A5 JP2002545643A JP2002545643A JP2004530414A5 JP 2004530414 A5 JP2004530414 A5 JP 2004530414A5 JP 2002545643 A JP2002545643 A JP 2002545643A JP 2002545643 A JP2002545643 A JP 2002545643A JP 2004530414 A5 JP2004530414 A5 JP 2004530414A5
Authority
JP
Japan
Prior art keywords
dietary supplement
iii
cell function
following
morinda citrifolia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2002545643A
Other languages
English (en)
Other versions
JP2004530414A (ja
Filing date
Publication date
Priority claimed from US09/997,588 external-priority patent/US20020068102A1/en
Application filed filed Critical
Publication of JP2004530414A publication Critical patent/JP2004530414A/ja
Publication of JP2004530414A5 publication Critical patent/JP2004530414A5/ja
Withdrawn legal-status Critical Current

Links

Claims (4)

  1. 加工されたモリンダシトリフォリア果汁を含む、スパーオキシドアニオンフリーラジカルを除去して細胞機能を増加させるための飲食サプリメント。
  2. 加工されたモリンダシトリフォリア果汁を含む、脂質ヒドロペルオキシドを除去して細胞機能を増加させるための飲食サプリメント。
  3. 少なくとも次の1つ:
    (i)調味料、
    (ii)甘味料、
    (iii)栄養成分、
    (iV)植物抽出物、及び
    (V)色素
    をさらに含む請求項1又は2に記載の飲食サプリメント。
  4. 少なくとも次の1つ:
    (i)ビタミンC
    (ii)海岸の松の皮の抽出物
    (iii)ぶどうの種の粉末
    をさらに含む、請求項1又は2に記載の飲食サプリメント。


JP2002545643A 2000-12-01 2001-12-03 人体における細胞障害の減少方法 Withdrawn JP2004530414A (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US25064800P 2000-12-01 2000-12-01
US25141700P 2000-12-05 2000-12-05
US09/997,588 US20020068102A1 (en) 2000-12-01 2001-11-29 Reducing cellular damage in the human body
PCT/US2001/047203 WO2002043664A2 (en) 2000-12-01 2001-12-03 Reducing cellular damage in the human body

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2008182543A Division JP2008289494A (ja) 2000-12-01 2008-07-14 人体における細胞障害の減少方法

Publications (2)

Publication Number Publication Date
JP2004530414A JP2004530414A (ja) 2004-10-07
JP2004530414A5 true JP2004530414A5 (ja) 2005-05-26

Family

ID=27400348

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002545643A Withdrawn JP2004530414A (ja) 2000-12-01 2001-12-03 人体における細胞障害の減少方法
JP2008182543A Pending JP2008289494A (ja) 2000-12-01 2008-07-14 人体における細胞障害の減少方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2008182543A Pending JP2008289494A (ja) 2000-12-01 2008-07-14 人体における細胞障害の減少方法

Country Status (5)

Country Link
US (1) US20020068102A1 (ja)
EP (1) EP1345616A4 (ja)
JP (2) JP2004530414A (ja)
AU (1) AU2002227300A1 (ja)
WO (1) WO2002043664A2 (ja)

Families Citing this family (41)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040192761A1 (en) * 2003-03-25 2004-09-30 Palu Afa Kehaati Preventative and treatment effects of morinda citrifolia as an aromatase inhibitor
US6855345B2 (en) * 2001-11-02 2005-02-15 Morinda, Inc. Preventative and treatment effects of Morinda citrifolia on diabetes and its related conditions
US8574642B2 (en) 2000-12-05 2013-11-05 Tahitian Noni International, Inc. Antiviral Morinda citrifolia L. based formulations and methods of administration
US20110217394A1 (en) * 2000-12-05 2011-09-08 Brett Justin West Iridoid Based Formulations
US8652546B2 (en) 2007-09-06 2014-02-18 Tahitian Noni International, Inc. Morinda citrifolia based formulations for regulating T cell immunomodulation in neonatal stock animals
US7244463B2 (en) 2005-10-18 2007-07-17 Tahitian Noni International, Inc. Garcinia mangostana L. enhanced animal food product
US20070196527A1 (en) * 2006-02-23 2007-08-23 Jensen Claude J Preventative and treatment effects of Morinda citrifolia on Osteoarthritis and its related conditions
US8790727B2 (en) * 2000-12-05 2014-07-29 Tahitian Noni International, Inc. Morinda citrifolia and iridoid based formulations
US20110171333A1 (en) * 2000-12-05 2011-07-14 Bryant Wadsworth Morinda Citrifolia Based Antioxidant and Antimicrobial Formulations for Improved Color Stability and Increased Shelf Life of Various Meat Products
JP2005511479A (ja) * 2001-04-17 2005-04-28 モリンダ・インコーポレーテッド モリンダシトリフォリア油および果汁の緩和作用
US7070813B2 (en) * 2001-11-02 2006-07-04 Morinda, Inc. Preventative and treatment effects of morinda citrifolia as a colon cancer cell growth inhibitor
US20110160057A1 (en) * 2001-11-14 2011-06-30 Bryant Wadsworth Morinda Citrifolia Based Antimicrobial Formulations
US7442395B2 (en) * 2002-11-14 2008-10-28 Tahitian Noni International, Inc. Formulation for treating candidiasis using Morinda citrifolia
NZ516367A (en) * 2001-12-24 2004-08-27 Enzo Nutraceuticals Ltd A flavonoid extract for use as an antioxidant
US20040013749A1 (en) * 2002-07-22 2004-01-22 Young D. Gary Antioxidant and immune boosting composition and methods of using
US7749535B2 (en) * 2003-01-15 2010-07-06 Neways, Inc. Compositions and methods using Morinda citrifolia
US8617870B2 (en) * 2003-03-13 2013-12-31 University Of Ottawa Antioxidant producing bacterium and uses thereof
US9358262B2 (en) * 2003-03-13 2016-06-07 University Of Ottawa Use of antioxidant-enriched fermented blueberry extracts in the treatment of diabetes
US20070184135A1 (en) * 2003-03-26 2007-08-09 Palu Afa K Morinda citrifolia-based formulation 5-LOX and 15-LOX
US20060269630A1 (en) * 2003-04-16 2006-11-30 Palu Afa K Morinda citrifolia as a 5-Lipoxygenase inhibitor
JP4073826B2 (ja) * 2003-06-04 2008-04-09 タヒチアン ノニ インターナショナル インコーポレーテッド ヤエヤマアオキの抽出物を含む農業用活力剤
US20070259060A1 (en) * 2003-08-12 2007-11-08 Mian-Ying Wang Formulations and Methods for Treating Breast Cancer with Morinda Citrifolia and Methylsulfonymethane
US20060024385A1 (en) * 2004-07-27 2006-02-02 Pedersen Mark A Metabolic capacity enhancing compositions and methods for use in a mammal
US7964234B2 (en) * 2004-10-28 2011-06-21 Neways, Inc. High mineral content dietary supplement
US20060204601A1 (en) * 2005-03-09 2006-09-14 Palu Afa K Formulations and methods for preventing and treating substance abuse and addiction
US20070122507A1 (en) * 2005-05-26 2007-05-31 Palu Afa K Histone deacetylase and tumor necrosis factor converting enzyme inhibition
US20060280818A1 (en) * 2005-05-26 2006-12-14 Palu Afa K Nicotinic acetylcholine receptor antagonist
US20070184137A1 (en) * 2005-11-29 2007-08-09 Palu Afa K Morinda Citrifolia L. Based Formulations for Inhibiting Matrix Metalloproteinase Enzymes
US20070154579A1 (en) * 2005-11-29 2007-07-05 Palu Afa K Morinda Citrifolia Based Formulation And Methods For Weight Management
US20070166417A1 (en) * 2005-11-29 2007-07-19 Palu Afa K Formulation and Methods for Use of Morinda Citrifolia Seed Oil
US20070281903A1 (en) * 2006-05-04 2007-12-06 Palu Afa K Morinda Citrifolia-Based Formulation 5-LOX And 15-LOX
US8535741B2 (en) 2006-05-12 2013-09-17 Morinda, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
US8025910B2 (en) 2006-05-12 2011-09-27 Tahitian Noni International, Inc. Method and composition for administering bioactive compounds derived from Morinda citrifolia
US20080206368A1 (en) * 2007-02-26 2008-08-28 Mian-Ying Wang Administration of Morinda Citrifolia L. Based Formulations to Increase Birth Rates
US20080317890A1 (en) * 2007-06-21 2008-12-25 Claude Jarakae Jensen Method for treating visual impairment through the prophylactic administration of a morinda citrifolia-based naturaceutical
CN101909639B (zh) * 2008-01-09 2013-09-11 营养株式会社 用于减轻在癌化学疗法中引起的氧化应激和/或副作用、或者改善癌化学疗法中的营养状态的组合物
US20090196944A1 (en) * 2008-02-01 2009-08-06 Brad Rawson Methods of Manufacture of Morinda Citrifolia Based Compositions for Treatment of Anti-Inflammatory Diseases through Inhibition of Cox-1, Cox-2, Interleukin -1beta, Interleukin-6, TNF-alpha, HLE, and iNOS
JP2010148417A (ja) * 2008-12-25 2010-07-08 Yoshigen:Kk 飲食品材料及びこれを用いた飲料
US20110206786A1 (en) * 2010-02-23 2011-08-25 Brett Justin West Acai and Iridoid Based Formulations
JP5473867B2 (ja) * 2010-11-09 2014-04-16 長谷川香料株式会社 (e,z,z)−2,4,7−トリデカトリエナールの製造方法
CN103859521B (zh) * 2014-04-08 2016-06-08 杜道林 一种海巴戟天然功能饮料及其制备方法

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1885401A (en) * 1930-07-28 1932-11-01 Vitamin Company Homogenized citrous fruit concentrate
CA1022726A (en) * 1974-04-24 1977-12-20 Canadian Industries Limited Process for the separation of sodium azide
US5288491A (en) * 1992-09-24 1994-02-22 Herbert Moniz Noni (Morinda Citrifolia) as a pharmaceutical product
FR2783137A1 (fr) * 1998-09-10 2000-03-17 Royal Tahiti Noni Composition a base d'extraits de morinda citrifolia
US6299925B1 (en) * 1999-06-29 2001-10-09 Xel Herbaceuticals, Inc. Effervescent green tea extract formulation
US6254913B1 (en) * 1999-08-27 2001-07-03 Morinda, Inc. Morinda citrifolia dietary fiber and method
US6214351B1 (en) * 1999-08-27 2001-04-10 Morinda, Inc. Morinda citrifolia oil

Similar Documents

Publication Publication Date Title
JP2004530414A5 (ja)
Chun et al. Superoxide radical scavenging activity of the major polyphenols in fresh plums
Ortuño et al. Citrus paradisi and Citrus sinensis flavonoids: Their influence in the defence mechanism against Penicillium digitatum
Omoregie et al. Antioxidant properties of methanolic extracts of some Nigerian plants on nutritionally-stressed rats
Daiponmak et al. Antiglycation capacity and antioxidant activities of different pigmented Thai rice
Muanda et al. Chemical composition and, cellular evaluation of the antioxidant activity of Desmodium adscendens leaves
Bhardwaj et al. Nutritional and therapeutic potential of bael (Aegle marmelos Corr.) fruit juice: a review
CA2422819A1 (en) Food supplement
WO2004041184A3 (en) Nutraceutical mangosteen composition
WO2002043664A3 (en) Reducing cellular damage in the human body
JP2009528818A (ja) 促進される吸収および生物学的利用のための全てが天然の多種ビタミンおよび多種ミネラル食事補助調合物
Grace et al. Novel value‐added uses for sweet potato juice and flour in polyphenol‐and protein‐enriched functional food ingredients
EP1721532B1 (en) Ellagic acid food supplement prepared from pomegranate seed
Zhang et al. Chemical composition and antioxidant properties of five edible Hymenomycetes mushrooms
Suresh et al. Anthocyanins from Indian cassava (Manihot esculenta Crantz) and its antioxidant properties
Nabavi et al. Antihemolytic and antioxidant activities of Biebersteinia multifida
JP2004529077A5 (ja)
Debnath et al. Antioxidant activity of Inonotus obliquus grown on germinated brown rice extracts
CN109258908A (zh) 一种玫瑰花口香糖的制备方法
Gaur et al. Antioxidant potential of the giant mushroom, Macrocybe gigantea (Agaricomycetes), from India in different drying methods
Yoo et al. Optimal extract methods of antioxidant compounds from coat of grape dreg
Kim et al. Preparation of minimally processed mulberry (Morus spp.) juices
WO2002045654A3 (en) Cancer preventative effect of morinda citrifolia
Gezici Cancer preventive and neuroprotective potentials of red hulls, kernels and oleo-gum resins from Pistachio
Kim et al. Antioxidant Activity of Methanol Extracts from $ Lactuca $$ indica$